Classification, molecular characterization, and the significance of Pten alteration in leiomyosarcoma

Sarcoma

Volumn 2012, Issue , 2012, Pages

  Grossmann, Allie H ^a   Layfield, Lester J ^a   Randall, R Lor ^a,b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE;

CLINICAL FEATURE; DISEASE ACTIVITY; GENOMIC INSTABILITY; HISTOPATHOLOGY; HUMAN; LEIOMYOSARCOMA; MEDICAL LITERATURE; MOLECULAR BIOLOGY; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; REPRODUCIBILITY; REVIEW; SMOOTH MUSCLE; TUMOR CLASSIFICATION;

EID: 84858147228     PISSN: 1357714X     EISSN: 13691643     Source Type: Journal    
DOI: 10.1155/2012/380896     Document Type: Review

References (76)

1. Weiss S. W., Goldblum J., Enzinger and Weiss's Soft Tissue Tumors 2007 Philadelphia, Pa, USA Elsevier
2. Weiss S. W., Smooth muscle tumors of soft tissue Advances in Anatomic Pathology 2002 9 6 351 359
3. Fletcher C. D. M., Unni K. K., Mertens F., Pathology and Genetics of Tumours of Soft Tissue and Bone 2002 Lyon, France IARC Press
4. Toro J. R., Travis L. B., Hongyu J. W., Zhu K., Fletcher C. D. M., Devesa S. S., Incidence patterns of soft tissue sarcomas, regardless of primary site, in the Surveillance, Epidemiology and End Results program, 19782001: an analysis of 26,758 cases International Journal of Cancer 2006 119 12 2922 2930 (Pubitemid 44846246)
5. Iwata J., Fletcher C. D. M., Immunohistochemical detection of cytokeratin and epithelial membrane antigen in leiomyosarcoma: a systematic study of 100 cases Pathology International 2000 50 1 7 14 (Pubitemid 30194087)
6. Coindre J. M., Terrier P., Guillou L., Doussal V. L., Collin F., Ranchre D., Sastre X., Vilain M. O., Bonichon F., Bui B. N., Predictive value of grade for metastasis development in the main histologic types of adult soft tissue sarcomas: a study of 1240 patients from the French Federation of Cancer Centers sarcoma group Cancer 2001 91 10 1914 1926 (Pubitemid 32424119)
7. Gustafson P., Dreinhofer K. E., Rydholm A., Soft tissue sarcoma should be treated at a tumor center: a comparison of quality of surgery in 375 patients Acta Orthopaedica Scandinavica 1994 65 1 47 50 (Pubitemid 24101911)
8. Gustafson P., Willen H., Baldetorp B., Ferno M., Akerman M., Rydholm A., Soft tissue leiomyosarcoma: a population-based epidemiologic and prognostic study of 48 patients, including cellular DNA content Cancer 1992 70 1 114 119
9. Kraft S., Fletcher C. D. M., Atypical intradermal smooth muscle neoplasms: clinicopathologic analysis of 84 cases and a reappraisal of cutaneous leiomyosarcoma American Journal of Surgical Pathology 2011 35 4 599 607
10. Svarvar C., Bohling T., Berlin O., Clinical course of nonvisceral soft tissue leiomyosarcoma in 225 patients from the scandinavian sarcoma group Cancer 2007 109 2 282 291 (Pubitemid 46106243)
11. Hashimoto H., Daimaru Y., Tsuneyoshi M., Enjoji M., Leiomyosarcoma of the external soft tissues. A clinicopathologic, immunohistochemical, and electron microscopic study Cancer 1986 57 10 2077 2088 (Pubitemid 16113789)
12. Bautista N., Su W., O'Connell T. X., Retroperitoneal soft-tissue sarcomas: prognosis and treatment of primary and recurrent disease American Surgeon 2000 66 9 832 836 (Pubitemid 30666926)
13. Stoeckle E., Coindre J. M., Bonvalot S., Kantor G., Terrier P., Bonichon F., Bui B. N., Prognostic factors in retroperitoneal sarcoma: a multivariate analysis of a series of 165 patients of the French Cancer Center Federation Sarcoma Group Cancer 2001 92 2 359 368 (Pubitemid 32664443)
14. Miettinen M., Fetsch J. F., Evaluation of biological potential of smooth muscle tumours Histopathology 2006 48 1 97 105
15. Hornick J. L., Fletcher C. D. M., Criteria for malignancy in nonvisceral smooth muscle tumors Annals of Diagnostic Pathology 2003 7 1 60 66 (Pubitemid 36292652)
16. Patil D. T., Laskin W. B., Fetsch J. F., Miettinen M., Inguinal smooth muscle tumors in women-a dichotomous group consisting of mllerian-type leiomyomas and soft tissue leiomyosarcomas: an analysis of 55 cases American Journal of Surgical Pathology 2011 35 3 315 324
17. Farshid G., Pradhan M., Goldblum J., Weiss S. W., Leiomyosarcoma of somatic soft tissues: a tumor of vascular origin with multivariate analysis of outcome in 42 cases American Journal of Surgical Pathology 2002 26 1 14 24 (Pubitemid 34019988)
18. Wile A. G., Evans H. L., Romsdahl M. M., Leiomyosarcoma of soft tissue: a clinicopathologic study Cancer 1981 48 4 1022 1032 (Pubitemid 11049108)
19. Neugut A. I., Sordillo P. P., Leiomyosarcomas of the extremities Journal of Surgical Oncology 1989 40 1 65 67 (Pubitemid 19039203)
20. Miyajima K., Oda Y., Oshiro Y., Tamiya S., Kinukawa N., Masuda K., Tsuneyoshi M., Clinicopathological prognostic factors in soft tissue leiomyosarcoma: a multivariate analysis Histopathology 2002 40 4 353 359 (Pubitemid 34595586)
21. Massi D., Beltrami G., Mela M. M., Pertici M., Capanna R., Franchi A., Prognostic factors in soft tissue leiomyosarcoma of the extremities: a retrospective analysis of 42 cases European Journal of Surgical Oncology 2004 30 5 565 572 (Pubitemid 38701882)
22. Kevorkian J., Cento D. P., Leiomyosarcoma of large arteries and veins Surgery 1973 73 3 390 400
23. Dew J., Hansen K., Hammon J., McCoy T., Levine E. A., Shen P., Leiomyosarcoma of the inferior vena cava: surgical management and clinical results American Surgeon 2005 71 6 497 501 (Pubitemid 43109876)
24. Hines O. J., Nelson S., Quinones-Baldrich W. J., Eilber F. R., Leiomyosarcoma of the inferior vena cava: prognosis and comparison with leiomyosarcoma of other anatomic sites Cancer 1999 85 5 1077 1083 (Pubitemid 29115586)
25. Hollenbeck S. T., Grobmyer S. R., Kent K. C., Brennan M. F., Surgical treatment and outcomes of patients with primary inferior vena cava leiomyosarcoma Journal of the American College of Surgeons 2003 197 4 575 579 (Pubitemid 38223842)
26. Ito H., Hornick J. L., Bertagnolli M. M., George S., Morgan J. A., Baldini E. H., Wagner A. J., Demetri G. D., Raut C. P., Leiomyosarcoma of the inferior vena cava: survival after aggressive management Annals of Surgical Oncology 2007 14 12 3534 3541 (Pubitemid 350160120)
27. Kieffer E., Alaoui M., Piette J. C., Cacoub P., Chiche L., Leiomyosarcoma of the inferior vena cava: experience in 22 cases Annals of Surgery 2006 244 2 289 295 (Pubitemid 44305545)
28. Mingoli A., Cavallaro A., Sapienza P., Di Marzo L., Feldhaus R. J., Cavallari N., International Registry of Inferior Vena Cava Leiomyosarcoma: analysis of a world series on 218 patients Anticancer Research 1996 16 5 3201 3205 (Pubitemid 26390275)
29. Illuminati G., Calio' F. G., D'Urso A., Giacobbi D., Papaspyropoulos V., Ceccanei G., Prosthetic replacement of the infrahepatic inferior vena cava for leiomyosarcoma Archives of Surgery 2006 141 9 919 924 (Pubitemid 44414441)
30. Laskin W. B., Fanburg-Smith J. C., Burke A. P., Kraszewska E., Fetsch J. F., Miettinen M., Leiomyosarcoma of the inferior vena cava: clinicopathologic study of 40 cases American Journal of Surgical Pathology 2010 34 6 873 881
31. Billings S. D., Folpe A. L., Weiss S. W., Do leiomyomas of deep soft tissue exist? An analysis of highly differentiated smooth muscle tumors of deep soft tissue supporting two distinct subtypes American Journal of Surgical Pathology 2001 25 9 1134 1142 (Pubitemid 32777712)
32. Paal E., Miettinen M., Retroperitoneal leiomyomas: a clinicopathologic and immunohistochemical study of 56 cases with a comparison to retroperitoneal leiomyosarcomas American Journal of Surgical Pathology 2001 25 11 1355 1363 (Pubitemid 33022050)
33. Rao U. N. M., Finkelstein S. D., Jones M. W., Comparative immunohistochemical and molecular analysis of uterine and extrauterine leiomyosarcomas Modern Pathology 1999 12 11 1001 1009
34. Tavassoli F. A., Norris H. J., Smooth muscle tumors of the vagina Obstetrics and Gynecology 1979 53 6 689 693 (Pubitemid 9153537)
35. Tavassoli F. A., Norris H. J., Smooth muscle tumors of the vulva Obstetrics and Gynecology 1979 53 2 213 217 (Pubitemid 9066928)
36. Nielsen G. P., Rosenberg A. E., Koerner F. C., Young R. H., Scully R. E., Smooth-muscle tumors of the vulva: a clinicopathological study of 25 cases and review of the literature American Journal of Surgical Pathology 1996 20 7 779 793 (Pubitemid 26230741)
37. Fletcher C. D. M., Kilpatrick S. E., Mentzel T., The difficulty in predicting behavior of smooth-muscle tumors in deep soft tissue American Journal of Surgical Pathology 1995 19 1 116 117
38. Danielson L. S., Menendez S., Attolini C. S. O., Guijarro M. V., Bisogna M., Wei J., Socci N. D., Levine D. A., Michor F., Hernando E., A differentiation-based microRNA signature identifies leiomyosarcoma as a mesenchymal stem cell-related malignancy American Journal of Pathology 2010 177 2 908 917
39. Francis P., Namls H. M., Mller C., Edén P., Fernebro J., Berner J. M., Bjerkehagen B., kerman M., Bendahl P. O., Isinger A., Rydholm A., Myklebost O., Nilbert M., Diagnostic and prognostic gene expression signatures in 177 soft tissue sarcomas: hypoxia-induced transcription profile signifies metastatic potential BMC Genomics 2007 8, article 73
40. Beck A. H., Lee C. H., Witten D. M., Gleason B. C., Edris B., Espinosa I., Zhu S., Li R., Montgomery K. D., Marinelli R. J., Tibshirani R., Hastie T., Jablons D. M., Rubin B. P., Fletcher C. D., West R. B., Van De Rijn M., Discovery of molecular subtypes in leiomyosarcoma through integrative molecular profiling Oncogene 2010 29 6 845 854
41. Beck A. H., Espinosa I., Edris B., Li R., Montgomery K., Zhu S., Varma S., Marinelli R. J., Van Rijn M. D., West R. B., The macrophage colony-stimulating factor 1 response signature in breast carcinoma Clinical Cancer Research 2009 15 3 778 787
42. Espinosa I., Beck A. H., Lee C. H., Zhu S., Montgomery K. D., Marinelli R. J., Ganjoo K. N., Nielsen T. O., Gilks C. B., West R. B., Van De Rijn M., Coordinate expression of colony-stimulating factor-1 and colony-stimulating factor-1-related proteins is associated with poor prognosis in gynecological and nongynecological leiomyosarcoma American Journal of Pathology 2009 174 6 2347 2356
43. Yang J., Du X., Chen K., Ylip A., Lazar A. J. F., Trent J., Lev D., Pollock R., Hao X., Hunt K., Zhang W., Genetic aberrations in soft tissue leiomyosarcoma Cancer Letters 2009 275 1 1 8
44. El-Rifai W., Sarlomo-Rikala M., Knuutila S., Miettinen M., DNA copy number changes in development and progression in leiomyosarcomas of soft tissues American Journal of Pathology 1998 153 3 985 990 (Pubitemid 28419051)
45. Otao-Joos M., Mechtersheimer G., Ohl S., Wilgenbus K. K., Scheurlen W., Lehnert T., Willeke F., Otto H. F., Lichter P., Joos S., Detection of chromosomal imbalances in leiomyosarcoma by comparative genomic hybridization and interphase cytogenetics Cytogenetics and Cell Genetics 2000 90 1-2 86 92
46. Wang R., Lu Y. J., Fisher C., Bridge J. A., Shipley J., Characterization of chromosome aberrations associated with soft-tissue leiomyosarcomas by twenty-four-color karyotyping and comparative genomic hybridization analysis Genes Chromosomes and Cancer 2001 31 1 54 64 (Pubitemid 32274133)
47. Lee J., Li S., Torbenson M., Liu Q. Z., Lind S., Mulvihill J. J., Bane B., Wang J., Leiomyosarcoma of the breast: a pathologic and comparative genomic hybridization study of two cases Cancer Genetics and Cytogenetics 2004 149 1 53 57 (Pubitemid 38177558)
48. Hu J., Rao U. N. M., Jasani S., Khanna V., Yaw K., Surti U., Loss of DNA copy number of 10q is associated with aggressive behavior of leiomyosarcomas: a comparative genomic hybridization study Cancer Genetics and Cytogenetics 2005 161 1 20 27 (Pubitemid 41096047)
49. Larramendy M. L., Kaur S., Svarvar C., Bohling T., Knuutila S., Gene copy number profiling of soft-tissue leiomyosarcomas by array-comparative genomic hybridization Cancer Genetics and Cytogenetics 2006 169 2 94 101 (Pubitemid 44308364)
50. Giacinti C., Giordano A., RB and cell cycle progression Oncogene 2006 25 38 5220 5227 (Pubitemid 44299080)
51. Meza-Zepeda L. A., Kresse S. H., Barragan-Polania A. H., Bjerkehagen B., Ohnstad H. O., Namls H. M., Wang J., Kristiansen B. E., Myklebost O., Array comparative genomic hybridization reveals distinct DNA copy number differences between gastrointestinal stromal tumors and leiomyosarcomas Cancer Research 2006 66 18 8984 8993 (Pubitemid 44521116)
52. Amant F., de la Rey M., Dorfling C. M., van der Walt L., Dreyer G., Dreyer L., Vergote I., Lindeque B. G., Van Rensburg E. J., PTEN mutations in uterine sarcomas Gynecologic Oncology 2002 85 1 165 169 (Pubitemid 34304028)
53. Saito T., Oda Y., Kawaguchi K. I., Takahira T., Yamamoto H., Tamiya S., Tanaka K., Matsuda S., Sakamoto A., Iwamoto Y., Tsuneyoshi M., PTEN/MMAC1 gene mutation is a rare event in soft tissue sarcomas without specific balanced translocations International Journal of Cancer 2003 104 2 175 178 (Pubitemid 36249792)
54. Kawaguchi K. I., Oda Y., Saito T., Takahira T., Yamamoto H., Tamiya S., Iwamoto Y., Tsuneyoshi M., Genetic and epigenetic alterations of the PTEN gene in soft tissue sarcomas Human Pathology 2005 36 4 357 363 (Pubitemid 40591805)
55. Zhang S., Yu D., PI(3)king apart PTEN's role in cancer Clinical Cancer Research 2010 16 17 4325 4330
56. Hernando E., Charytonowicz E., Dudas M. E., Menendez S., Matushansky I., Mills J., Socci N. D., Behrendt N., Ma L., Maki R. G., Pandolfi P. P., Cordon-Cardo C., The AKT-mTOR pathway plays a critical role in the development of leiomyosarcomas Nature Medicine 2007 13 6 748 753 (Pubitemid 46889749)
57. Dhingra S., Rodriguez M. E., Shen Q., Duan X., Stanton M. L., Chen L., Zhang R., Brown R. E., Constitutive activation with overexpression of the mTORC2-phospholipase D1 pathway in uterine leiomyosarcoma and STUMP: morphoproteomic analysis with therapeutic implications International Journal of Clinical and Experimental Pathology 2011 4 2 134 146
58. Garg G., Short A., Liu J. R., Akt-mTOR pathway in uterine leiomyosarcoma Journal of Clinical Oncology 2011 29. abstract no. 5040
59. Okuno S., Bailey H., Mahoney M. R., Adkins D., Maples W., Fitch T., Ettinger D., Erlichman C., Sarkaria J. N., A phase 2 study of temsirolimus (CCI-779) in patients with soft tissue sarcomas: a study of the mayo phase 2 Consortium (P2C) Cancer 2011 117 15 3468 3475
60. Italiano A., Kind M., Stoeckle E., Jones N., Coindre J.-M., Bui B., Temsirolimus in advanced leiomyosarcomas: patterns of response and correlation with the activation of the mammalian target of rapamycin pathway Anti-Cancer Drugs 2011 22 5 463 467
61. Chawla S. P., Tolcher A. W., Staddon A. P., Survival results with AP23573, a novel mTOR inhibitor, in patients (pts) with advanced soft tissue or bone sarcomas: update of phase II trial Journal of Clinical Oncology 2007 25 18S. abstract no. 10076
62. Meek D. W., Knippschild U., Posttranslational modification of MDM2 Molecular Cancer Research 2003 1 14 1017 1026 (Pubitemid 38044977)
63. Shen W. H., Balajee A. S., Wang J., Wu H., Eng C., Pandolfi P. P., Yin Y., Essential role for nuclear PTEN in maintaining chromosomal integrity Cell 2007 128 1 157 170 (Pubitemid 46048887)
64. Levine A. J., Wu M. C., Chang A., Silver A., Atiyeh E. F., Lin J., Epstein C. B., The spectrum of mutations at the p53 locus Annals of the New York Academy of Sciences 1995 768 111 128 (Pubitemid 26078725)
65. Waite K. A., Eng C., Protean PTEN: form and function American Journal of Human Genetics 2002 70 4 829 844 (Pubitemid 34259300)
66. Kawaguchi K. I., Oda Y., Saito T., Yamamoto H., Takahira T., Tamiya S., Iwamoto Y., Tsuneyoshi M., Death-associated protein kinase (DAP kinase) alteration in soft tissue leiomyosarcoma: promoter methylation or homozygous deletion is associated with a loss of DAP kinase expression Human Pathology 2004 35 10 1266 1271 (Pubitemid 39361651)
67. Ito M., Barys L., O'Reilly T., Young S., Gorbatcheva B., Monahan J., Zumstein-Mecker S., Choong P. F., Dickinson I., Crowe P., Hemmings C., Desai J., Thomas D. M., Lisztwan J., Comprehensive mapping of p53 pathway alterations reveals an apparent role for both SNP309 and MDM2 amplification in sarcomagenesis Clinical Cancer Research 2011 17 3 416 426
68. Wang W., Emergence of a DNA-damage response network consisting of Fanconi anaemia and BRCA proteins Nature Reviews Genetics 2007 8 10 735 748 (Pubitemid 47429206)
69. Xing D., Scangas G., Nitta M., He L., Xu A., Ioffe Y. J. M., Aspuria P. J., Hedvat C. Y., Anderson M. L., Oliva E., Karlan B. Y., Mohapatra G., Orsulic S., A role for BRCA1 in uterine leiomyosarcoma Cancer Research 2009 69 21 8231 8235
70. Quinn B. A., Brake T., Hua X., Baxter-Jones K., Litwin S., Ellenson L. H., Connolly D. C., Induction of ovarian leiomyosarcomas in mice by conditional inactivation of Brca1 and p53 PLoS One 2009 4 12
71. Taubert H., Schuster K., Brinck U., Bartel F., Kappler M., Lautenschlger C., Bache M., Trump C., Schmidt H., Holzhausen H. J., Wrl P., Schlott T., Loss of heterozygosity at 12q14-15 often occurs in stage I soft tissue sarcomas and is associated with MDM2 amplification in tumors at various stages Modern Pathology 2003 16 11 1109 1116 (Pubitemid 37414205)
72. Ragazzini P., Gamberi G., Pazzaglia L., Serra M., Magagnoli G., Ponticelli F., Ferrari C., Ghinelli C., Alberghini M., Bertoni F., Picci P., Benassi M. S., Amplification of CDK4, MDM2, SAS and GLI genes in leiomyosarcoma, alveolar and embryonal rhabdomyosarcoma Histology and Histopathology 2004 19 2 401 411 (Pubitemid 38443902)
73. Yap T. A., Sandhu S. K., Carden C. P., De Bono J. S., Poly (ADP-ribose) polymerase (PARP) inhibitors: exploiting a synthetic lethal strategy in the clinic CA Cancer Journal for Clinicians 2011 61 1 31 49
74. Mendes-Pereira A. M., Martin S. A., Brough R., McCarthy A., Taylor J. R., Kim J. S., Waldman T., Lord C. J., Ashworth A., Synthetic lethal targeting of PTEN mutant cells with PARP inhibitors EMBO Molecular Medicine 2009 1 6-7 315 322
75. McEllin B., Camacho C. V., Mukherjee B., Hahm B., Tomimatsu N., Bachoo R. M., Burma S., PTEN loss compromises homologous recombination repair in astrocytes: implications for glioblastoma therapy with temozolomide or poly(ADP-Ribose) polymerase inhibitors Cancer Research 2010 70 13 5457 5464
76. Dedes K. J., Wetterskog D., Mendes-Pereira A. M., Preclinical evaluation of PARP inhibition as a treatment for endometrioid endometrial carcinomas Journal of Clinical Oncology 2010 28 15s. abstract no. 5065